Nektar Therapeutics (NKTR) PT Lowered to $41 at BMO Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel rattle AI trade
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 38.41 -0.77 (1.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.18 | 52 Week High | $19.98 | |||
| Open | $39.00 | 52 Week Low | $10.52 | |||
| Day High | $39.30 | P/E | N/A | |||
| Day Low | $38.00 | EPS | $-1.45 | |||
| Volume | 141,265 | |||||
